Nijhuis M - Search Results

1

Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia.

van Elden LJ, van Kraaij MG, Nijhuis M, Hendriksen KA, Dekker AW, Rozenberg-Arska M, van Loon AM. van Elden LJ, et al. Among authors: nijhuis m. Clin Infect Dis. 2002 Jan 15;34(2):177-83. doi: 10.1086/338238. Epub 2001 Dec 4. Clin Infect Dis. 2002. PMID: 11740705 Free PMC article.

2

Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).

Schuurman R, Nijhuis M, van Leeuwen R, Schipper P, de Jong D, Collis P, Danner SA, Mulder J, Loveday C, Christopherson C, et al. Schuurman R, et al. Among authors: nijhuis m. J Infect Dis. 1995 Jun;171(6):1411-9. doi: 10.1093/infdis/171.6.1411. J Infect Dis. 1995. PMID: 7539472

3

Sensitive procedure for the amplification of HIV-1 RNA using a combined reverse-transcription and amplification reaction.

Nijhuis M, Boucher CA, Schuurman R. Nijhuis M, et al. Biotechniques. 1995 Aug;19(2):178-80, 182. Biotechniques. 1995. PMID: 8527130 No abstract available.

4

Human immunodeficiency virus type 1 drug susceptibility determination by using recombinant viruses generated from patient sera tested in a cell-killing assay.

Boucher CA, Keulen W, van Bommel T, Nijhuis M, de Jong D, de Jong MD, Schipper P, Back NK. Boucher CA, et al. Among authors: nijhuis m. Antimicrob Agents Chemother. 1996 Oct;40(10):2404-9. doi: 10.1128/AAC.40.10.2404. Antimicrob Agents Chemother. 1996. PMID: 8891152 Free PMC article.

5

Lamivudine-resistant human immunodeficiency virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivo.

Nijhuis M, Schuurman R, de Jong D, van Leeuwen R, Lange J, Danner S, Keulen W, de Groot T, Boucher CA. Nijhuis M, et al. J Infect Dis. 1997 Aug;176(2):398-405. doi: 10.1086/514056. J Infect Dis. 1997. PMID: 9237704

6

Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy.

Nijhuis M, Boucher CA, Schipper P, Leitner T, Schuurman R, Albert J. Nijhuis M, et al. Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14441-6. doi: 10.1073/pnas.95.24.14441. Proc Natl Acad Sci U S A. 1998. PMID: 9826719 Free PMC article.

7

Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy.

Nijhuis M, Schuurman R, de Jong D, Erickson J, Gustchina E, Albert J, Schipper P, Gulnik S, Boucher CA. Nijhuis M, et al. AIDS. 1999 Dec 3;13(17):2349-59. doi: 10.1097/00002030-199912030-00006. AIDS. 1999. PMID: 10597776

8

Simultaneous detection of influenza viruses A and B using real-time quantitative PCR.

van Elden LJ, Nijhuis M, Schipper P, Schuurman R, van Loon AM. van Elden LJ, et al. Among authors: nijhuis m. J Clin Microbiol. 2001 Jan;39(1):196-200. doi: 10.1128/JCM.39.1.196-200.2001. J Clin Microbiol. 2001. PMID: 11136770 Free PMC article.

9

Clinical diagnosis of influenza virus infection: evaluation of diagnostic tools in general practice.

van Elden LJ, van Essen GA, Boucher CA, van Loon AM, Nijhuis M, Schipper P, Verheij TJ, Hoepelman IM. van Elden LJ, et al. Among authors: nijhuis m. Br J Gen Pract. 2001 Aug;51(469):630-4. Br J Gen Pract. 2001. PMID: 11510391 Free PMC article.

10

Selection of zidovudine resistance mutations and escape of human immunodeficiency virus type 1 from antiretroviral pressure in stavudine-treated pediatric patients.

Maxeiner HG, Keulen W, Schuurman R, Bijen M, de Graaf L, van Wijk A, Back N, Kline MW, Boucher CA, Nijhuis M. Maxeiner HG, et al. Among authors: nijhuis m. J Infect Dis. 2002 Apr 15;185(8):1070-6. doi: 10.1086/339817. Epub 2002 Apr 1. J Infect Dis. 2002. PMID: 11930317

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results